About USV Peptides
USV Peptides is a company based in Mumbai (India) founded in 1961. It operates as a B2B. The company has 6,981 employees as of March 31, 2024. USV Peptides operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Aperiam Bio, among others.
- Headquarter Mumbai, India
- Employees 6981 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Usv Private Limited
- Date of Incorporation 25 Aug, 1961
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$565.63 M (USD)12.2as on Mar 31, 2024
-
Net Profit
$160.91 M (USD)19.71as on Mar 31, 2024
-
EBITDA
$204.19 M (USD)9.13as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
6981
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of USV Peptides
Detailed funding history for USV Peptides
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by USV Peptides
Investment portfolio details for USV Peptides
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - USV Peptides
Detailed financials for USV Peptides
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Usv Peptides Comparisons
Peer comparison for USV Peptides
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of USV Peptides
USV Peptides operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Aperiam Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| Locked | Locked | Locked |
Industrial and therapeutic proteins are manufactured by Aperiam Bio.
|
|
| Locked | Locked | Locked |
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs.
|
Detailed competitors of USV Peptides
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Usv Peptides
Complete news archive for USV Peptides
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about USV Peptides
USV Peptides was founded in 1961.
USV Peptides is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at USV Peptides is 6,981.
Annual revenue of USV Peptides is $565.63M as on Mar 31, 2024.
USV Peptides, established in 1961, excels in providing healthcare solutions, advancing biotech innovations, peptide synthesis, and custom manufacturing. Serves as a CDMO specializing in custom, GMP, and cosmetic peptide synthesis services for clients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
USV Peptides's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.